Trials / Completed
CompletedNCT01067599
Novel Determinants and Measures of Smokeless Tobacco Use: Study 2
Novel Determinants and Measures of Smokeless Tobacco Use: Study 2 Effects of Switching Levels of Nicotine and TSNA in Products on Smokeless Tobacco Use
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 278 (actual)
- Sponsor
- University of Minnesota · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The research project will determine the level of nicotine in ST products that will lead to the greatest reduction in toxicant exposure
Detailed description
This is a randomized, multi-site trial determining the effects of switching smokeless tobacco (ST) users to lower toxicant ST products which vary in nicotine levels on biomarkers of exposure and patterns of use. ST users will undergo a two week baseline assessment period and then randomly assigned to one of three oral tobacco products (lower NNK plus NNN product with three different levels of nicotine) for a period of 8-weeks. Follow-up will occur at 9 and 20 weeks.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Low nicotine | Comparison of different dosages of nicotine effect on tobacco use patterns, subjective response and biomarker levels. |
| OTHER | Medium nicotine | Comparison of different dosages of nicotine effect on tobacco use patterns, subjective response and biomarker levels. |
| OTHER | High nicotine | Comparison of different dosages of nicotine effect on tobacco use patterns, subjective response and biomarker levels. |
Timeline
- Start date
- 2012-03-01
- Primary completion
- 2015-08-01
- Completion
- 2016-10-01
- First posted
- 2010-02-11
- Last updated
- 2018-02-26
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01067599. Inclusion in this directory is not an endorsement.